138 related articles for article (PubMed ID: 2257212)
1. Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx.
Esteban F; Concha A; Delgado M; Pérez-Ayala M; Ruiz-Cabello F; Garrido F
Br J Cancer; 1990 Dec; 62(6):1047-51. PubMed ID: 2257212
[TBL] [Abstract][Full Text] [Related]
2. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. II. Clinicopathologic correlations with the loss of expression of the HLA ABC antigens].
Esteban F; Concha A; Delgado M; Ruiz-Cabello F; Garrido F
Acta Otorrinolaringol Esp; 1990; 41(6):359-68. PubMed ID: 2092725
[TBL] [Abstract][Full Text] [Related]
3. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.
Esteban F; Concha A; Huelin C; Pérez-Ayala M; Pedrinaci S; Ruiz-Cabello F; Garrido F
Int J Cancer; 1989 Mar; 43(3):436-42. PubMed ID: 2647639
[TBL] [Abstract][Full Text] [Related]
4. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
[TBL] [Abstract][Full Text] [Related]
5. MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up.
Esteban F; Redondo M; Delgado M; Garrido F; Ruiz-Cabello F
Br J Cancer; 1996 Dec; 74(11):1801-4. PubMed ID: 8956796
[TBL] [Abstract][Full Text] [Related]
6. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens].
Esteban F; Concha A; Ruiz-Cabello F; Garrido F
Acta Otorrinolaringol Esp; 1990; 41(5):297-303. PubMed ID: 2076309
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.
Ruiz-Cabello F; Lopez Nevot MA; Gutierrez J; Oliva MR; Romero C; Ferron A; Esteban F; Huelin C; Piris MA; Rivas C
Clin Exp Metastasis; 1989; 7(2):213-26. PubMed ID: 2493352
[TBL] [Abstract][Full Text] [Related]
8. [Research into the human leucocyte antigen I deletion and local lymphocytes infiltration in laryngeal carcinoma].
Niu C; Liu X; Zhou W; Jing L; Du B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Jun; 37(3):215-8. PubMed ID: 12772327
[TBL] [Abstract][Full Text] [Related]
9. [Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in laryngeal squamous cell carcinoma].
Zeng Q; Wang XL; Xu ZG; Lü N; Zheng S; Zhao QZ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):234-40. PubMed ID: 22805026
[TBL] [Abstract][Full Text] [Related]
10. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.
López-Nevot MA; Esteban F; Ferrón A; Gutiérrez J; Oliva MR; Romero C; Huelin C; Ruiz-Cabello F; Garrido F
Br J Cancer; 1989 Feb; 59(2):221-6. PubMed ID: 2649129
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma.
Mizukami Y; Kono K; Maruyama T; Watanabe M; Kawaguchi Y; Kamimura K; Fujii H
Br J Cancer; 2008 Nov; 99(9):1462-7. PubMed ID: 18841157
[TBL] [Abstract][Full Text] [Related]
13. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx.
Liu M; Lawson G; Delos M; Jamart J; Chatelain B; Remacle M; Marbaix E
Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):28-34. PubMed ID: 12520353
[TBL] [Abstract][Full Text] [Related]
15. HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites.
Mattijssen V; De Mulder PH; Schalkwijk L; Manni JJ; Van 't Hof-Grootenboer B; Ruiter DJ
Int J Cancer Suppl; 1991; 6():95-100. PubMed ID: 2066187
[TBL] [Abstract][Full Text] [Related]
16. Expression of the nonclassical HLA-G and HLA-E molecules in laryngeal lesions as biomarkers of tumor invasiveness.
Silva TG; Crispim JC; Miranda FA; Hassumi MK; de Mello JM; Simões RT; Souto F; Soares EG; Donadi EA; Soares CP
Histol Histopathol; 2011 Dec; 26(12):1487-97. PubMed ID: 21972088
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
[TBL] [Abstract][Full Text] [Related]
18. MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer.
Andratschke M; Pauli C; Stein M; Chaubal S; Wollenberg B
Anticancer Res; 2003; 23(2B):1467-71. PubMed ID: 12820411
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.
Esteban F; Ruiz-Cabello F; Concha A; Pérez-Ayala M; Sánchez-Rozas JA; Garrido F
Clin Exp Metastasis; 1990; 8(4):319-28. PubMed ID: 2350918
[TBL] [Abstract][Full Text] [Related]
20. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.
Ryu KS; Lee YS; Kim BK; Park YG; Kim YW; Hur SY; Kim TE; Kim IK; Kim JW
Exp Mol Med; 2001 Sep; 33(3):136-44. PubMed ID: 11642549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]